Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1

We tested the hypothesis that ex vivo hepatocyte gene therapy can correct the metabolic disorder in fumarylacetoacetate hydrolase–deficient (Fah(−/−)) pigs, a large animal model of hereditary tyrosinemia type 1 (HT1). Recipient Fah(−/−)pigs underwent partial liver resection and hepatocyte isolation...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Transl Med
Main Authors: Hickey, Raymond D., Mao, Shennen A., Glorioso, Jaime, Elgilani, Faysal, Amiot, Bruce, Chen, Harvey, Rinaldo, Piero, Marler, Ronald, Jiang, Huailei, DeGrado, Timothy R., Suksanpaisan, Lukkana, O’Connor, Michael K., Freeman, Brittany L., Ibrahim, Samar H., Peng, Kah Whye, Harding, Cary O., Ho, Chak-Sum, Grompe, Markus, Ikeda, Yasuhiro, Lillegard, Joseph B., Russell, Stephen J., Nyberg, Scott L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5477771/
https://ncbi.nlm.nih.gov/pubmed/27464750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/scitranslmed.aaf3838
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados